Results 251 to 260 of about 532,597 (317)

Correction: NT-I7, a novel long-acting interleukin-7, promotes anti-PD-1 efficacy in an autologous humanized melanoma model

Scientific Reports
Yee Peng Phoon, Alexandra A. Wolfarth, Pauline Funchain, Jennifer S. Ko, Donghoon Choi, Eliska Dedkova, Daniela Duarte Bateman, Jessica Corvin, Jan J. Melenhorst, Brian R. Gastman   +9 more
doaj   +1 more source

From phage display to tumor microcirculation regulation: A bibliometric review of phage in cancer immunotherapy research (2000-2024). [PDF]

Medicine (Baltimore)
Wang H, Yin J, Yin H.
europepmc   +1 more source

O‐GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer

Advanced Science, EarlyView.
This article unveils a critical mechanism of immune evasion in bladder cancer, which the O‐GlcNAc modification of TAP1 disrupts antigen presentation. This modification triggers HLA‐A degradation, shielding tumor cells from CD8+ T cell attack. The findings highlight targeting this pathway as a promising therapeutic avenue to sensitize tumors to ...
Jinpeng Wu, Xueting Ren, Zhen Zhai, Lu Wang, Liang Liang, Zengqi Tan, Jiazhen Zhao, Yuxuan Han, Yuhan Li, Feng Guan, Xiang Li   +10 more
wiley   +1 more source

Dynamic inflammatory biomarkers as prognostic indicators in advanced breast cancer patients receiving PD-1 inhibitors. [PDF]

Ther Adv Med Oncol
Wang N, Yi P, Lu Q, Zhong Y, Xue C, Zhang P, Wang S, Yuan Z, Shi Y, Chen H, Xu F, Jiang K.   +11 more
europepmc   +1 more source

Editorial: Targeting the immunogenicity of cancer cells in anticancer therapies: from innate immunity to adaptive immune system implications. [PDF]

Front Immunol
Martínez-Torres AC, Correa-Basurto J, Scott-Algara D.   +2 more
europepmc   +1 more source

Aging is associated with the outcomes of immune checkpoint blockade in renal cell carcinoma. [PDF]

J Immunother Cancer
Huang Z, Zhou J, Zheng Z, Zhao H, Zhao B, Zeng R.   +5 more
europepmc   +1 more source

Editorial: Overcoming resistance to immune checkpoint inhibitors: mechanisms and strategies in cancer therapy. [PDF]

Front Immunol
Piccinelli M, Pizzutilo EG, Gemelli M, Sarhan D, Cavalieri S.   +4 more
europepmc   +1 more source

Mechanisms and Applications of Manganese-Based Materials in Tumor Immunotherapy. [PDF]

Molecules
Kong X, Zhang C, Hu H, Chen Y, Gao W, Chen R.   +5 more
europepmc   +1 more source